The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study

References

• Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: Results of linkage with the California cancer registry. Am J Obstet Gynecol 2003;189:1128–35.
   PubMed Web of Science ®Google Scholar
• Pentheroudakis G, Pavlidis N. Cancer and pregnancy: Poena magna, not anymore. Eur J Cancer 2006;42:126–40.
   PubMed Web of Science ®Google Scholar
• Azim HA, Jr., Peccatori FA. Treatment of cancer during pregnancy: The need for tailored strategies. J Clin Oncol 2010;28:e302–3; author reply e4.
   PubMed Web of Science ®Google Scholar
• Azim HA, Jr., Peccatori FA, Pavlidis N. Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev 2010;36:101–9.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: Maternal and fetal outcomes. Cancer J 2010;16:76–82.
   PubMed Web of Science ®Google Scholar
• Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, . Breast cancer in pregnancy: Recommendations of an international consensus meeting. Eur J Cancer 2010;46:3158–68.
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA, Jr., Scarfone G, Gadducci A, Bonazzi C, Gentilini O, . Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat 2009;115:591–4.
   PubMed Web of Science ®Google Scholar
• Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, . Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219–26.
   PubMed Web of Science ®Google Scholar
• Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, . The impact of pregnancy on breast cancer outcomes in women < or = 35 years. Cancer 2009; 115:1174–84.
   PubMedGoogle Scholar
• Aziz S, Pervez S, Khan S, Siddiqui T, Kayani N, Israr M, . Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol Res Pract 2003;199:15–21.
   PubMedGoogle Scholar
• Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, . Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008;112:71–8.
   PubMed Web of Science ®Google Scholar
• Moreira WB, Brandao EC, Soares AN, Lucena CE, Antunes CM. Prognosis for patients diagnosed with pregnancy-associated breast cancer: A paired case-control study. Sao Paulo Med J 2010;128:119–24.
   PubMed Web of Science ®Google Scholar
• Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, . Effect of pregnancy on prognosis for young women with breast cancer. Lancet 1994;343:1587–9.
   PubMed Web of Science ®Google Scholar
• Halaska MJ, Pentheroudakis G, Strnad P, Stankusova H, Chod J, Robova H, . Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: A matched controlled study. Breast J 2009; 15:461–7.
   PubMed Web of Science ®Google Scholar
• Gentilini O, Cremonesi M, Toesca A, Colombo N, Peccatori F, Sironi R, . Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 2010;37:78–83.
   PubMed Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403–10.
   PubMed Web of Science ®Google Scholar
• Colleoni M, Rotmensz N, Maisonneuve P, Sonzogni A, Pruneri G, Casadio C, . Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 2007;18:1632–40.
   PubMed Web of Science ®Google Scholar
• Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, . Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst 2008;100:207–12.
   PubMed Web of Science ®Google Scholar
• Hugh J, Hanson J, Cheang MC, Nielsen TO, Perou CM, Dumontet C, . Breast cancer subtypes and response to docetaxel in node-positive breast cancer: Use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol 2009;27:1168–76.
   PubMed Web of Science ®Google Scholar
• Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, . Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: Analysis of case-control study in Japan. Jpn J Cancer Res 1992;83:1143–9.
   PubMedGoogle Scholar
• Loibl S, Amant F, Kaufmann M, Ring A, Sileny H, Giermek J, . 313 patients with breast cancer during pregnancy – Results from a prospective and retrospective registry (GBG-20/BIG02-03). San Antonio Breast Cancer Symposium 2010; S6–2.
   Google Scholar
• Azim HA, Jr., Del Mastro L, Scarfone G, Peccatori FA. Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring and more. Breast 2011;20:1–6.
   PubMed Web of Science ®Google Scholar
• Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, . In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253–70.
   PubMed Web of Science ®Google Scholar
• Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, . Control of mammary stem cell function by steroid hormone signalling. Nature 2010;465:798–802.
   PubMed Web of Science ®Google Scholar
• Kim JB, Stein R, O'Hare MJ. Tumour-stromal interactions in breast cancer: The role of stroma in tumourigenesis. Tumour Biol 2005;26:173–85.
   PubMed Web of Science ®Google Scholar
• Rouzier R, Werkoff G, Uzan C, Mir O, Gligorov J, Selleret L, . Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting. Ann Oncol 2011;22:1582–7.
   PubMed Web of Science ®Google Scholar